| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |